1 |
/
[
Koo JC;Lee SY;Chun HJ;Cheong YH;Choi JS;Kawabata S;Miyagi M;Tsunasawa S;Ha KS;Bae DW;Han CD;Lee BL;Cho MJ.
] /
Biochim Biophys Acta
|
2 |
/
[
Kim SH.
] /
J Kor Ori Med
|
3 |
/
[
Yamada H;Nagai T;Takemoto N;Endoh H;Kiyohara H;Kawamura H;Otsuka Y.
] /
Biochem Biophys Res Commun
|
4 |
/
[
Collins MKL;Rivas AL.
] /
Trends in Cell Biology
|
5 |
/
[
Williams GT;Smith CA.
] /
Cell
|
6 |
/
[
Levine AJ.
] /
|
7 |
/
[
Lane DP.
] /
Nature
|
8 |
/
[
Miyashita T;Harigai M;Hanada M;Reed JC.
] /
Cancer Res
|
9 |
/
[
Yonish-Rouach E;Resnitzky D;Lotem J;Sachs L;kimchi A;Oren M.
] /
|
10 |
/
[
Wang E;Lee MJ.;Pandey S.
] /
J Cell Biochem
|
11 |
/
[
Kastan MB;Zhan Q;El-Deiry WS;Carrier F;Jacks T;Walsh WV;Plunkett BS;Fornace AJ.
] /
Cell
|
12 |
Wild-type p53 can down-modulate the activity of various promoters
/
[
Ginsberg D;Mechta F;Yaniv M;Oren M.
] /
Proc Natl Acad Sci
|
13 |
/
[
Kim DH;Kim SH.
] /
J Kor Ori Med
|
14 |
Apoptosis-regulating proteins as targets for drug discovery
/
[
Reed JC.
] /
Trends Mol Med
|
15 |
Apoptosis
/
[
Wyllie AH.
] /
Br J Cancer
|
16 |
Bax Plays a Pivotal Role in Thapsigargin-induced Apoptosis of Human Colon Cancer HCT116 Cells by Controlling Smac/Diablo and Omi/HtrA2 Release from Mitochondria
/
[
Yamaguchi H;Bhalla K;Wang HG.
] /
Cancer Research
|
17 |
/
[
Findly HW;Gu L;Yeager AM;Zhou M.
] /
Blood
|
18 |
/
[
Schlesinger PH;Gross A;Yin AM;Yamanoto K;Saito M;Waksman G;Korsmeyer SJ.
] /
Natl Acad Sci
|
19 |
/
[
Tu Y;Feng-hao Xu;Jin Liu;Versco R;Berenson J;Fady C;Lichtanstein A.
] /
Blood
|
20 |
/
[
Lisovsky M;Estrov Z;Zhang X;Consoli U;Sanchez- Williams G;Snell V;Munker R;Goodacre A;Mack DH;Vartikar J;Pipas JM;Laimins LA.
] /
Nature
|
21 |
/
[
Itoh N;Tsujimoto Y;Nagata S.
] /
The journal of immunology
|
22 |
/
[
Yin C;Knudson CM;Korsmeyer SJ;Van-Dyke T.
] /
Nature
|
23 |
/
[
Strobel T;Swanson L;Korsmeter S;Cannistra SA.
] /
Proc Natl Acad Sci
|